Business

Aurora Cannabis buying Anandia Laboratories in all-stock $115M deal

Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115 million.

Aurora has been gearing up in anticipation of the legalization of recreational marijuana in Canada

Last month, Aurora Cannabis announced a $3.2-billion all-stock offer for rival licensed marijuana producer MedReleaf,the largest-ever deal in Canada's cannabis industry. (Canadian Press)

Aurora Cannabis Inc. has signed an agreement to buy Anandia Laboratories Inc. in an all-stock deal valued at $115 million.

Anandia provides research and development services as well as analytical testing for clients licensed under Canada's medical cannabis rules.

Aurora CEO Terry Booth says the deal expands his company's capabilities and will help accelerate product development.

The companies say that Anandia's cannabis testing services will remain operationally independent of Aurora.

Aurora has been gearing up in anticipation of the legalization of recreational marijuana in Canada expected later this year.

Last month, the company announced a $3.2-billion all-stock offer for rival licensed marijuana producer MedReleaf,the largest-ever deal in Canada's cannabis industry.

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversation  Create account

Already have an account?

now